Browsing: weightloss

– Millions of Medicare beneficiaries can now access GLP-1 weight-loss medication for $50 a month under a new option called the Medicare GLP-1 Bridge Program

As GLP-1 medications such as Ozempic and Wegovy gain popularity for weight loss, new research suggests they may offer another potential benefit: slowing some of the biological processes associated with ageing

The growing popularity of GLP-1 medications such as Ozempic, Wegovy, and Rybelsus has largely been driven by their ability to help people lose weight, improve blood sugar control, and reduce the risk of cardiovascular disease. Now, researchers have uncovered another possible benefit. A new clinical trial suggests that semaglutide, the active ingredient in those medications,…

Canadian employers are broadening access to glucagon-like peptide-1 (GLP-1) drugs for weight loss, with the share offering that coverage rising to 37 percent in 2026 from 17 percent in 2024. 

Mounjaro and Zepbound combined for $12.8 billion of Lilly’s $19.8 billion in first-quarter revenue

Curtis Lancaster – South of England Sun, July 12, 2026 at 6:10 AM UTC Lisa Halls, from Southampton said she was 27-stone at her heaviest

Weight‑loss drugs vs bariatric surgery: Who should choose what, experts explain | Mint

Weight-loss injections have changed the way many people approach obesity, offering hope where years of dieting often brought disappointment. Yet leading health and nutrition experts now say these medicines are only one part of the journey. Without the right food, regular movement and emotional support, the benefits may not last, and new challenges can emerge

As weight-loss pills are now hitting the UK market, experts have warned of the dangers of counterfeit pills and how to spot them

As they slim down, UK and US users of GLP-1 jabs and pills are changing their spending habits – and their wardrobes